EP Patent

EP4622630A1 — Compositions of dry powder formulations of messenger rna and methods of use thereof

Assigned to Translate Bio Inc · Expires 2025-10-01 · 1y expired

What this patent protects

The present disclosure provides stable, dry powder messenger RNA formulations for therapeutic use, and methods of making and using the same.

USPTO Abstract

The present disclosure provides stable, dry powder messenger RNA formulations for therapeutic use, and methods of making and using the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP4622630A1
Jurisdiction
EP
Classification
—
Expires
2025-10-01
Drug substance claim
No
Drug product claim
No
Assignee
Translate Bio Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.